Search

Takeda Vaccines Inc - EP4153222A1 - Zika Virus Antibody Detection

Takeda Vaccines, Inc. has obtained European Patent Application EP4153222A1 for a method of detecting Zika virus-specific antibodies. The application names inventors Perez-Guzman, Nascimento, Dean, and Braun and covers IPC classifications spanning immunological preparations, peptides, and nucleic acid detection methods. The patent is designated across 34 European states including Germany, France, the United Kingdom, Italy, and Spain.